- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
SHEN Dandan, YANG Zhonghui, HUANG Ji, et al. Effect of safflower yellow injection on the pharmacokinetics and anticoagulation of aspirin[J]. J China Pharm Univ, 2024, 55(6): 795 − 800. DOI: 10.11665/j.issn.1000-5048.2024031902
|
This article explores the interaction between aspirin and safflower yellow injection from the perspective of pharmacokinetics, combined with pharmacological indicators such as anticoagulation. Quantitative HPLC analysis was performed for the detection of salicylic acid in plasma samples, and the pharmacokinetic effects of aspirin in combination with safflower yellow injection on aspirin’s hydrolyzed product salicylic acid was evaluated. Thromboxane B2 (TXB2) and 6-keto prostaglandin F1 in plasma were determined using enzyme-linked immunosorbent assay and fully automated biochemical analyzer α (6-keto-PGF1) α）, and the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and serum creatinine (Scr) were tested to evaluate the anticoagulant effect and safety indicators after long-term combined use of the two drugs, including liver and kidney function and cardiac pathological examination. The results showed that, compared with the aspirin group, there was no significant difference (P>0.05) in the plasma pharmacokinetic parameters of rats with combined use of safflower yellow injection. In addition, the plasma TXB2 in the combination group was significantly reduced compared to the aspirin group (P<0.01), yet with no significant difference for 6-keto-PGF1 α (P>0.05). There was no statistically significant difference in the levels of serum BUN, Scr, AST, and ALT between the two groups before and after treatment (P>0.05). These results suggest that the combination of aspirin and safflower yellow injection does not cause significant change in the blood concentration of salicylic acid. It does not affect the antiplatelet effect of aspirin.
| [1] |
Chinese SC, Cardiology PR. CMAR, Cardiac CCGGS, et al. Chinese guidelines for primary prevention of cardiovascular diseases basic edition[J]. Chin J Cardiol(中华心血管病杂志), 2023, 51(4): 343-363.
|
| [2] |
Lang YT, Zhu CL, Tao WQ, et al. Pharmacoeconomic evaluation of clopidogrel versus aspirin for secondary prevention of ischemic stroke[J]. Chin Pharmacy(中国药房), 2023, 34(7): 837-843.
|
| [3] |
Qi W, Miu Y, Huang L, Huang L, et al. Evaluation of rationality of off-label application of TCM injection for promoting blood circulation and removing stasis[J]. Strait Pharm J(海峡药学), 2023, 35(4): 75-79.
|
| [4] |
Zhang HW, Chai YY, Chen HY, et al. Research progress of aspirin resistance mechanism[J]. Chin J Pharm Univ(中国药科大学学报), 2014, 45(4): 496-503.
|
| [5] |
Wei W, Zhang XJ, Xiao BG, et al. Hydroxy safflower yellow in acute cerebral infarction with myocardial ischemia: a randomized, open label and controlled study[J]. Chin J Stroke (中国卒中杂志), 2021, 16(4): 343-347.
|
| [6] |
Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes[J]. J Appl Toxicol, 2001, 21(1): 15-23. doi: 10.1002/jat.727
|
| [7] |
Peterson DA, Gerrard JM, Rao GH, et al. Salicylic acid inhibition of the irreversible effect of acetylsalicyclic aicd on prostaglandin synthetase may be due to competition for the enzyme cationic binding site[J]. Prostaglandins Med, 1981, 6(2): 161-164. doi: 10.1016/0161-4630(81)90087-2
|
| [8] |
Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase[J]. Nat Struct Biol, 1995, 2(8): 637-643. doi: 10.1038/nsb0895-637
|
| [9] |
Merino J, Livio M, Rajtar G, et al. Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation[J]. Biochem Pharmacol, 1980, 29(8): 1093-1096. doi: 10.1016/0006-2952(80)90401-3
|
| [10] |
González-Correa JA, Muñoz-Marín J, López-Villodres JA, et al. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils[J]. Pharmacol Res, 2007, 56(2): 168-174. doi: 10.1016/j.phrs.2007.05.006
|
| [11] |
Gladding PA, Webster MW, Farrell HB, et al. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers[J]. Am J Cardiol, 2008, 101(7): 1060-1063. doi: 10.1016/j.amjcard.2007.11.054
|
| [12] |
Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials[J]. BMJ, 2006, 332(7553): 1302-1308. doi: 10.1136/bmj.332.7553.1302
|
| [13] |
Clark DWJ, Layton D, Shakir SAW. Do some inhibitors of COX-2 increase the risk of thromboembolic events? : linking pharmacology with pharmacoepidemiology[J]. Drug Saf, 2004, 27 (7): 427-456.
|
| [14] |
Niu FX, Liu Y, Liu YN et al. Pharmacological action and research progress of hydroxylsafflower yellow A[J]. Chin J Pharm(中国药学杂志), 2021, 56(17): 1372-1377.
|
| [15] |
Li JP, Xu XJ, Zhang QY et al. Study on the pharmacokinetic interaction characteristics of aspirin andDanhong injection[J]. Chin Tradit Herbal Drugs(中草药), 2021, 52(12): 3619-3629.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：301748
DownLoad: